Facilities & Operation

The integration of artificial intelligence is transforming how drug manufacturers anticipate market needs, allowing for a level of accuracy in demand planning that was previously unattainable through traditional statistical methods.

The transition toward evidence-based decision making is enabling pharmaceutical organizations to synchronize production with real-world demand, reducing waste and ensuring that life-saving medications are always available when and where they are needed.

Navigating the complexities of pharmaceutical distribution requires a fundamental shift from traditional reactive models to robust, proactive strategies that prioritize long-term stability and patient safety over short-term cost savings.

NVIDIA and Eli Lilly and Company have announced the creation of a new NVIDIA-Lilly AI lab, designed to apply artificial intelligence to some of...

Daiichi Sankyo has recently made an announcement of its plans to invest almost 300 billion yen, which is equivalent to $1.9 billion, when it...

Samsung Biologics has agreed to acquire 100% of Human Genome Sciences from GSK, a move that secures the company’s first U.S.-based biologics manufacturing site...

Smart factory technologies are transforming pharmaceutical manufacturing through the integration of automation, IoT sensors, and centralized control systems. This comprehensive guide explores how connected equipment and real-time monitoring enhance productivity, minimize downtime, and improve operational visibility while maintaining strict regulatory compliance in controlled manufacturing environments.